PMH13 Differences Between Patients Undergoing Augmentation or Switching of Antipsychotic Medications During Treatment of Schizophrenia von Ascher-Svanum, H, Brnabic, A.J, Lawson, T, Kinon, B.J, Stauffer, V.L, Feldman, P.D, Kelin, K

Volltext

P.3.c.053 Do early changes in triglycerides predict later changes during olanzapine treatment? von Poole-Hoffmann, V, Case, M.G, Stauffer, V.L, Jacobson, J, Conley, R

Volltext

P.3.c.060 Differences in early responders/early non-responders to atypical antipsychotics on functional outcomes in schizophrenia von Kinon, B, Chen, L, Stauffer, V.L, Ascher-Svanum, H, Zhou, W, Tomori, O, Kollack-Walker, S, Kane, J.M, Kapur, S

Volltext

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia von Fijal, B A, Kinon, B J, Kapur, S, Stauffer, V L, Conley, R R, Jamal, H H, Kane, J M, Witte, M M, Houston, J P

Volltext

Manic-like symptoms in schizophrenic patients treated with olanzapine, haloperidol, and placebo von Baker, R.W., Juliar, B.E., Stauffer, V.L.

Volltext

Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies von Bangs, M.E., Kudrow, D., Wang, S.F., Oakes, T.M., Terwindt, G.M., Magis, D., Yunes-Medina, L., Stauffer, V.L.

Volltext bestellen

Olanzapine improves tardive dyskinesia in patients with schizophrenia von Kollack-Walker, S., Kinon, B.J., Stauffer, V.L., Wang, L., Thi, K.T.

Volltext

Favorable anticholinergic profile of olanzapine in elderly patients with dementia von Kinon, B.J., Stauffer, V.L., Wang, L., Kennedy, J.S.

Volltext

Rapid reduction in hyperprolactinemia upon switching treatment to olanzapine from conventional antipsychotic drugs or risperidone von Kinon, B.J., Basson, B., Wang, J., Malcolm, S.K., Stauffer, V.L.

Volltext

Effect of chronic olanzapine treatment on the course of presumptive tardive dyskinesia von Kinon, B.J., Milton, D.R., Stauffer, V.L., Basson, B.R.

Volltext

Depression during mania: treatment response to olanzapine or placebo von Baker, R.W., Tohen, M., Risser, R.C., Stauffer, V.L., Breier, A., Tollefson, G.D.

Volltext

Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies (vol 20, 25, 2020) von Bangs, M.E., Kudrow, D., Wang, S.F., Oakes, T.M., Terwindt, G.M., Magis, D., Yunes-Medina, L., Stauffer, V.L.

Volltext bestellen